Ulcerative Colitis

Clinical Trial Info

  • Category

    Current Enrolling Clinical Trials

Ulcerative colitis

Ulcerative colitis (UC) is an autoimmune response that causes inflammation and ulcers (sores) in your digestive tract. UC usually affects the rectum and lower part of the colon.

Symptoms of ulcerative colitis can include: diarrhea, abdominal pain, weight loss, inflammation of the eyes and skin.


ClinicalTrials.gov Study Details

Stool Collection Study from Seres

Clinical Study Protocol M14-234 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

Clinical Study Protocol M14-675 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis

A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of GS-4875 in Subjects with Moderately to Severely Active Ulcerative Colitis


Contact Research

Physician Investigator

Photo of Bharat K Misra M.D.
Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)
4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.
Photo of Mark Fleisher M.D.
Gastroenterologist Encore Borland Groover Clinical Research
4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.